# The Study of Dachengqi Decoction Combined With Probiotic L92 to Improve the Prognosis of Patients With Severe Abdominal Hypertension

> **NCT04517045** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 752 (estimated)

## Conditions studied

- Dachengqi Decoction
- Probiotic L92

## Interventions

- **DRUG:** Dachengqi decoction
- **DRUG:** probiotic L9
- **OTHER:** Conventional treatment

## Key facts

- **NCT ID:** NCT04517045
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 752 (ESTIMATED)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04517045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04517045, "The Study of Dachengqi Decoction Combined With Probiotic L92 to Improve the Prognosis of Patients With Severe Abdominal Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04517045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*